SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6fn1'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1BX4_A_ADNA355_1 (PROTEIN (ADENOSINE KINASE))	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	ARG A 40 VAL A 33 ILE A 146 ALA A 357 ILE A 181	None	0.84A	1bx4A-6fn1A: undetectable	1bx4A-6fn1A: 14.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E71_M_ASCM995_0 (MYROSINASE MA1)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 7	ILE A1120 ARG A1187 PHE A 266 PHE A1085	None	1.17A	1e71M-6fn1A: undetectable	1e71M-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E72_M_ASCM995_0 (MYROSINASE MA1)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 7	ILE A1120 ARG A1187 PHE A 266 PHE A1085	None	1.16A	1e72M-6fn1A: undetectable	1e72M-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1E73_M_ASCM995_0 (MYROSINASE MA1)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 6	ILE A1120 ARG A1187 PHE A 266 PHE A1085	None	1.17A	1e73M-6fn1A: undetectable	1e73M-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ETB_2_T442129_1 (TRANSTHYRETIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 6	LEU A 967 THR A 100 ALA A 964 LEU A 962	None	1.18A	1etb2-6fn1A: undetectable	1etb2-6fn1A: 19.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1K6C_B_MK1B902_1 (POL POLYPROTEIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 10	ARG A1221 LEU A1198 ALA A1184 GLY A1177 GLY A1178	None	0.93A	1k6cA-6fn1A: undetectable	1k6cA-6fn1A: 20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ODI_B_ADNB1237_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 11	THR A 332 GLY A 206 GLU A 73 SER A 336 ILE A 204	None	1.46A	1odiB-6fn1A: undetectable	1odiB-6fn1A: 16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ODI_C_ADNC1238_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 11	THR A 332 GLY A 206 GLU A 73 SER A 336 ILE A 204	None	1.41A	1odiC-6fn1A: undetectable	1odiC-6fn1A: 16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ODI_D_ADND1237_1 (PURINE NUCLEOSIDE PHOSPHORYLASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 11	THR A 332 GLY A 206 GLU A 73 SER A 336 ILE A 204	None	1.46A	1odiD-6fn1A: undetectable	1odiD-6fn1A: 16.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SDU_B_MK1B902_1 (PROTEASE RETROPEPSIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 11	ARG A1221 LEU A1198 ALA A1184 GLY A1177 GLY A1178	None	0.93A	1sduA-6fn1A: undetectable	1sduA-6fn1A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SDV_B_MK1B902_1 (PROTEASE RETROPEPSIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 10	ARG A1221 LEU A1198 ALA A1184 GLY A1177 GLY A1178	None	0.93A	1sdvA-6fn1A: undetectable	1sdvA-6fn1A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_A_ROFA502_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	LEU A 832 TYR A 997 THR A1001 SER A 695 PHE A 696	None	1.11A	1xoqA-6fn1A: undetectable	1xoqA-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XOQ_B_ROFB501_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	LEU A 832 TYR A 997 THR A1001 SER A 695 PHE A 696	None	1.12A	1xoqB-6fn1A: undetectable	1xoqB-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZQ9_A_SAMA4000_1 (PROBABLE DIMETHYLADENOSINE TRANSFERASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	3 / 3	GLY A 609 GLU A 607 ASN A 610	None	0.71A	1zq9A-6fn1A: undetectable	1zq9A-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2EIN_W_CHDW1060_0 (CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART CYTOCHROME C OXIDASE SUBUNIT 1)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 6	ILE A 895 TYR A 489 ARG A 488 THR A 482	None	1.03A	2einN-6fn1A: 0.3 2einW-6fn1A: undetectable	2einN-6fn1A: undetectable 2einW-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QHF_A_NCAA493_0 (CHORISMATE SYNTHASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 11	MET A 38 ILE A 185 ALA A 357 ALA A 361 VAL A 364	None	0.94A	2qhfA-6fn1A: undetectable	2qhfA-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VAV_F_CSCF1383_2 (ACETYL-COA--DEACETYL CEPHALOSPORIN C ACETYLTRANSFERASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	3 / 3	LEU A 137 MET A 931 MET A 877	None	0.95A	2vavF-6fn1A: undetectable	2vavF-6fn1A: 10.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2WX2_B_TPFB1460_1 (LANOSTEROL 14-ALPHA-DEMETHYLASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 8	TYR A 789 ALA A 249 ALA A 253 LEU A 796	None	1.03A	2wx2B-6fn1A: undetectable	2wx2B-6fn1A: 10.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Y6R_B_CTCB1385_0 (TETX2 PROTEIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 8	MET A 196 PHE A 199 GLY A 202 GLY A 225	None	0.95A	2y6rB-6fn1A: undetectable	2y6rB-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YZQ_A_SAMA6075_0 (PUTATIVE UNCHARACTERIZED PROTEIN PH1780)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	ILE A 460 ILE A 387 ILE A 468 GLU A 467 PRO A 384	None	1.24A	2yzqA-6fn1A: undetectable	2yzqA-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ZIA_A_CL9A401_2 (DEOXYCYTIDINE KINASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 4	VAL A 462 ASP A 456 LEU A 391 ARG A 466	None	1.26A	2ziaA-6fn1A: 1.3	2ziaA-6fn1A: 11.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BOG_D_DHID8_0 (6.5 KDA GLYCINE-RICH ANTIFREEZE PROTEIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 4	SER A1070 GLY A1069 GLY A1072 GLY A1248	None	0.80A	3bogB-6fn1A: undetectable 3bogD-6fn1A: undetectable	3bogB-6fn1A: undetectable 3bogD-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BUR_A_TESA339_1 (3-OXO-5-BETA-STEROID 4-DEHYDROGENASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 10	ILE A 460 THR A 580 SER A 418 ASN A 390 VAL A 416	None	1.43A	3burA-6fn1A: undetectable	3burA-6fn1A: 14.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ELZ_B_CHDB151_0 (ILEAL BILE ACID-BINDING PROTEIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 10	ILE A 582 ILE A 584 GLY A 426 VAL A 591 LEU A 414	None	1.41A	3elzB-6fn1A: undetectable	3elzB-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP2_A_PNNA5001_0 (TRANSCRIPTIONAL REGULATOR TCAR)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 8	ASN A 902 THR A 905 LEU A 909 ARG A 542	None	0.92A	3kp2A-6fn1A: 1.2 3kp2B-6fn1A: undetectable	3kp2A-6fn1A: undetectable 3kp2B-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KP6_A_SALA3005_1 (TRANSCRIPTIONAL REGULATOR TCAR)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 8	ASN A 902 THR A 905 LEU A 909 ARG A 542	None	0.98A	3kp6A-6fn1A: undetectable	3kp6A-6fn1A: 21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N3I_A_ROCA201_2 (PROTEASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 6	PRO A 65 ILE A 59 GLY A 61 VAL A 132	None	0.87A	3n3iA-6fn1A: undetectable	3n3iA-6fn1A: 16.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NLY_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 8	PHE A 78 GLU A 971 SER A 969 VAL A 963	None	1.34A	3nlyA-6fn1A: undetectable 3nlyB-6fn1A: undetectable	3nlyA-6fn1A: 14.60 3nlyB-6fn1A: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NMU_J_SAMJ228_0 (FIBRILLARIN-LIKE RRNA/TRNA 2'-O-METHYLTRANSFERA SE NOP5/NOP56 RELATED PROTEIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 11	ALA A 868 ILE A 980 PHE A 982 ALA A 979 GLN A 724	None None ZQU A1305 ( 4.6A) None ZQU A1304 (-4.2A)	1.24A	3nmuB-6fn1A: 3.4 3nmuJ-6fn1A: undetectable	3nmuB-6fn1A: undetectable 3nmuJ-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OF4_B_ACTB313_0 (NITROREDUCTASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	3 / 3	ALA A 571 VAL A 568 GLN A 536	None	0.68A	3of4B-6fn1A: undetectable	3of4B-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OGP_A_017A200_2 (FIV PROTEASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 10	LEU A 858 VAL A 864 GLY A 843 ILE A 847 LEU A 861	None	1.33A	3ogpB-6fn1A: undetectable	3ogpB-6fn1A: 23.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PGH_A_FLPA701_1 (CYCLOOXYGENASE-2)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	VAL A1059 VAL A1078 LEU A1081 VAL A1093 LEU A1057	None	0.93A	3pghA-6fn1A: undetectable	3pghA-6fn1A: 7.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PRS_A_RITA1001_2 (ENDOTHIAPEPSIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	GLY A 603 GLY A 429 THR A 434 TYR A 400 ILE A 408	None	1.15A	3prsA-6fn1A: undetectable	3prsA-6fn1A: 11.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3RQL_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 8	PHE A 78 GLU A 971 SER A 969 VAL A 963	None	1.33A	3rqlA-6fn1A: 2.8 3rqlB-6fn1A: undetectable	3rqlA-6fn1A: 14.60 3rqlB-6fn1A: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UQ6_B_ADNB401_2 (ADENOSINE KINASE, PUTATIVE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 5	LEU A 883 GLY A 880 MET A 191 PHE A 941	None	1.03A	3uq6B-6fn1A: undetectable	3uq6B-6fn1A: 12.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UWL_D_FOZD316_0 (THYMIDYLATE SYNTHASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	LEU A 424 LEU A 409 GLY A 603 PHE A 600 ILE A 396	None	1.03A	3uwlD-6fn1A: undetectable	3uwlD-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VAQ_B_ADNB401_2 (PUTATIVE ADENOSINE KINASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 4	LEU A 883 GLY A 880 MET A 191 PHE A 941	None	1.06A	3vaqB-6fn1A: undetectable	3vaqB-6fn1A: 12.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WG7_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 6	ILE A 895 TYR A 489 ARG A 488 THR A 482	None	1.02A	3wg7N-6fn1A: 3.1 3wg7W-6fn1A: undetectable	3wg7N-6fn1A: undetectable 3wg7W-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A6D_A_SAMA1350_0 (HYDROXYINDOLE O-METHYLTRANSFERASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	PHE A 696 GLY A 829 GLY A 826 ILE A 699 ALA A 833	None	1.04A	4a6dA-6fn1A: undetectable	4a6dA-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4A6E_A_SAMA1349_0 (HYDROXYINDOLE O-METHYLTRANSFERASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	PHE A 696 GLY A 829 GLY A 826 ILE A 699 ALA A 833	None	1.12A	4a6eA-6fn1A: undetectable	4a6eA-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4CAP_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 8	PHE A 78 GLU A 971 SER A 969 VAL A 963	None	1.34A	4capA-6fn1A: undetectable 4capB-6fn1A: undetectable	4capA-6fn1A: 14.60 4capB-6fn1A: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EB6_C_VLBC503_1 (TUBULIN BETA CHAIN TUBULIN ALPHA CHAIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	VAL A1034 THR A1064 ILE A1114 VAL A1079 ILE A1229	None	1.41A	4eb6B-6fn1A: undetectable 4eb6C-6fn1A: undetectable	4eb6B-6fn1A: 11.49 4eb6C-6fn1A: 12.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KOE_F_TR6F101_1 (DNA TOPOISOMERASE 4 SUBUNIT A DNA TOPOISOMERASE 4 SUBUNIT B E-SITE DNA2)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 6	SER A1234 ARG A1232 GLY A1178 ASP A1206	None	0.95A	4koeA-6fn1A: undetectable 4koeB-6fn1A: undetectable 4koeC-6fn1A: undetectable	4koeA-6fn1A: 10.55 4koeB-6fn1A: 10.55 4koeC-6fn1A: 16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KOE_H_TR6H101_1 (DNA TOPOISOMERASE 4 SUBUNIT A DNA TOPOISOMERASE 4 SUBUNIT B E-SITE DNA4)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 7	ARG A1232 SER A1234 GLY A1178 ASP A1206	None	0.91A	4koeA-6fn1A: undetectable 4koeB-6fn1A: undetectable 4koeD-6fn1A: undetectable	4koeA-6fn1A: 10.55 4koeB-6fn1A: 10.55 4koeD-6fn1A: 16.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4KT0_A_PQNA2001_1 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1 PHOTOSYSTEM I REACTION CENTER SUBUNIT IX)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 11	SER A 830 GLY A 829 LEU A 783 GLY A 780 LEU A 257	None	1.14A	4kt0A-6fn1A: 3.4 4kt0J-6fn1A: 1.5	4kt0A-6fn1A: 8.85 4kt0J-6fn1A: 23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4LA0_B_198B601_1 (SERUM ALBUMIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 9	LEU A1259 ALA A1073 LYS A1251 GLU A1252 LEU A1065	None	1.12A	4la0B-6fn1A: undetectable	4la0B-6fn1A: 7.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O1E_A_C2FA3000_0 (DIHYDROPTEROATE SYNTHASE DHPS)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	ILE A 839 ILE A 867 GLY A 988 SER A 991 ASN A 720	None	1.10A	4o1eA-6fn1A: undetectable	4o1eA-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O1E_B_C2FB4000_0 (DIHYDROPTEROATE SYNTHASE DHPS)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	ILE A 839 ILE A 867 GLY A 988 SER A 991 ASN A 720	None	1.08A	4o1eB-6fn1A: undetectable	4o1eB-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8F_B_BRLB501_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 6	ILE A 718 GLY A 721 ILE A 848 ILE A 839	None	0.63A	4o8fB-6fn1A: undetectable	4o8fB-6fn1A: 16.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OLT_B_GCSB302_1 (CHITOSANASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 5	ARG A1046 THR A1045 ASP A 804 TYR A1086	None	1.46A	4oltB-6fn1A: undetectable	4oltB-6fn1A: 16.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVW_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	6 / 11	THR A 175 ALA A 896 THR A 897 ALA A 899 GLY A 891 SER A 892	None	1.38A	4qvwK-6fn1A: undetectable 4qvwL-6fn1A: undetectable	4qvwK-6fn1A: 17.70 4qvwL-6fn1A: 15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVW_K_BO2K301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	6 / 11	THR A 175 ALA A 896 THR A 897 GLY A 891 SER A 892 SER A 922	None	1.48A	4qvwK-6fn1A: undetectable 4qvwL-6fn1A: undetectable	4qvwK-6fn1A: 17.70 4qvwL-6fn1A: 15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVW_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	6 / 11	THR A 175 ALA A 896 THR A 897 ALA A 899 GLY A 891 SER A 892	None	1.39A	4qvwY-6fn1A: undetectable 4qvwZ-6fn1A: undetectable	4qvwY-6fn1A: 17.70 4qvwZ-6fn1A: 15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVW_Y_BO2Y301_1 (PROTEASOME SUBUNIT BETA TYPE-5 PROTEASOME SUBUNIT BETA TYPE-6)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	6 / 11	THR A 175 ALA A 896 THR A 897 GLY A 891 SER A 892 SER A 922	None	1.48A	4qvwY-6fn1A: undetectable 4qvwZ-6fn1A: undetectable	4qvwY-6fn1A: 17.70 4qvwZ-6fn1A: 15.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4V3Y_B_H4BB760_1 (NITRIC OXIDE SYNTHASE, BRAIN)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 8	PHE A 78 GLU A 971 SER A 969 VAL A 963	None	1.35A	4v3yA-6fn1A: undetectable 4v3yB-6fn1A: undetectable	4v3yA-6fn1A: 14.60 4v3yB-6fn1A: 14.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5B1B_W_CHDW101_0 (CYTOCHROME C OXIDASE SUBUNIT 1 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 7	ILE A 895 PHE A 915 TYR A 489 ARG A 488 THR A 482	None	1.42A	5b1bN-6fn1A: 2.9 5b1bW-6fn1A: undetectable	5b1bN-6fn1A: undetectable 5b1bW-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5DXE_A_ESTA1000_1 (ESTROGEN RECEPTOR)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 8	GLU A 607 LEU A 614 MET A 615 LEU A 588	None	0.96A	5dxeA-6fn1A: 3.1	5dxeA-6fn1A: 17.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E26_A_PAUA602_0 (PANTOTHENATE KINASE 2, MITOCHONDRIAL)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 7	GLY A 299 SER A 765 GLY A 762 ALA A 301	None	0.82A	5e26A-6fn1A: undetectable 5e26B-6fn1A: undetectable	5e26A-6fn1A: undetectable 5e26B-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5E26_D_PAUD601_0 (PANTOTHENATE KINASE 2, MITOCHONDRIAL)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 8	ALA A 301 GLY A 299 SER A 765 GLY A 762	None	0.84A	5e26C-6fn1A: undetectable 5e26D-6fn1A: undetectable	5e26C-6fn1A: undetectable 5e26D-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5FSA_A_X2NA590_1 (CYP51 VARIANT1)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	PHE A 313 ILE A 734 PHE A 335 PHE A 982 PHE A 977	None None ZQU A1304 ( 3.8A) ZQU A1305 ( 4.6A) None	1.08A	5fsaA-6fn1A: undetectable	5fsaA-6fn1A: 10.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IKT_B_TLFB601_0 (PROSTAGLANDIN G/H SYNTHASE 2)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	VAL A1059 VAL A1078 LEU A1081 VAL A1093 LEU A1057	None	1.00A	5iktB-6fn1A: undetectable	5iktB-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5IWU_A_ERYA404_1 (MACROLIDE 2'-PHOSPHOTRANSFERAS E II)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 6	GLY A1072 ASP A1199 ILE A1227 TYR A1043	None	1.13A	5iwuA-6fn1A: undetectable	5iwuA-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KR0_A_478A101_1 (PROTEASE E35D-APV)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 9	ALA A1239 ASP A1240 ILE A1229 VAL A1244 ILE A1242	None	1.16A	5kr0A-6fn1A: undetectable	5kr0A-6fn1A: 21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5MVM_A_PFLA510_1 (PROTON-GATED ION CHANNEL)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 9	ILE A 217 ALA A 219 ILE A 220 ALA A 312 LEU A 311	None	1.12A	5mvmA-6fn1A: 3.6 5mvmE-6fn1A: 1.6	5mvmA-6fn1A: 17.50 5mvmE-6fn1A: 17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_A_486A801_1 (GLUCOCORTICOID RECEPTOR)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	LEU A 412 LEU A 409 GLY A 603 GLY A 602 LEU A 424	None	0.97A	5uc1A-6fn1A: undetectable	5uc1A-6fn1A: 21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5UC1_B_486B801_2 (GLUCOCORTICOID RECEPTOR)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	LEU A 412 LEU A 409 GLY A 603 GLY A 602 LEU A 424	None	0.96A	5uc1B-6fn1A: undetectable	5uc1B-6fn1A: 21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5V5Z_A_1YNA602_1 (LANOSTEROL 14-ALPHA DEMETHYLASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	PHE A 313 ILE A 734 PHE A 335 PHE A 982 PHE A 977	None None ZQU A1304 ( 3.8A) ZQU A1305 ( 4.6A) None	1.20A	5v5zA-6fn1A: undetectable	5v5zA-6fn1A: 9.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YW0_A_ACTA411_0 (UNCHARACTERIZED PROTEIN KDOO)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	3 / 3	LYS A 289 LEU A 286 ARG A 285	None	0.95A	5yw0A-6fn1A: undetectable	5yw0A-6fn1A: undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZRF_D_EVPD101_1 ()	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 5	GLY A 190 ASP A 187 GLN A 945 MET A 948	None None ZQU A1305 (-3.8A) ZQU A1305 (-3.4A)	1.30A	5zrfB-6fn1A: undetectable	5zrfB-6fn1A: 8.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B89_A_NOVA403_2 (LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 6	ARG A 542 ARG A 546 LEU A 544 ALA A 571	None	0.91A	6b89B-6fn1A: 21.5	6b89B-6fn1A: 18.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6CBZ_A_ESTA601_1 (ESTROGEN RECEPTOR)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	4 / 8	GLU A 607 LEU A 614 MET A 615 LEU A 588	None	1.00A	6cbzA-6fn1A: undetectable	6cbzA-6fn1A: 24.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HQB_A_PQNA2001_0 (PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1 PHOTOSYSTEM I REACTION CENTER SUBUNIT IX)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 10	SER A 830 GLY A 829 LEU A 783 GLY A 780 LEU A 257	None	1.21A	6hqbA-6fn1A: 4.4 6hqbJ-6fn1A: 1.4	6hqbA-6fn1A: 19.05 6hqbJ-6fn1A: 23.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6QXS_B_FOZB403_0 (THYMIDYLATE SYNTHASE)	6fn1	HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM) (Homo sapiens)	5 / 12	LEU A 424 LEU A 409 GLY A 603 PHE A 600 ILE A 396	None	1.08A	6qxsB-6fn1A: undetectable	6qxsB-6fn1A: undetectable

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1BX4_A_ADNA355_1","PROTEIN (ADENOSINE KINASE)","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ARG A  40;VAL A  33;ILE A 146;ALA A 357;ILE A 181","None","0.84A","1bx4A-6fn1A:undetectable","1bx4A-6fn1A:14.57"],["1E71_M_ASCM995_0","MYROSINASE MA1","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"ILE A1120;ARG A1187;PHE A 266;PHE A1085","None","1.17A","1e71M-6fn1A:undetectable","1e71M-6fn1A:undetectable"],["1E72_M_ASCM995_0","MYROSINASE MA1","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"ILE A1120;ARG A1187;PHE A 266;PHE A1085","None","1.16A","1e72M-6fn1A:undetectable","1e72M-6fn1A:undetectable"],["1E73_M_ASCM995_0","MYROSINASE MA1","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"ILE A1120;ARG A1187;PHE A 266;PHE A1085","None","1.17A","1e73M-6fn1A:undetectable","1e73M-6fn1A:undetectable"],["1ETB_2_T442129_1","TRANSTHYRETIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"LEU A 967;THR A 100;ALA A 964;LEU A 962","None","1.18A","1etb2-6fn1A:undetectable","1etb2-6fn1A:19.66"],["1K6C_B_MK1B902_1","POL POLYPROTEIN;POL POLYPROTEIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ARG A1221;LEU A1198;ALA A1184;GLY A1177;GLY A1178","None","0.93A","1k6cA-6fn1A:undetectable","1k6cA-6fn1A:20.39"],["1ODI_B_ADNB1237_1","PURINE NUCLEOSIDE PHOSPHORYLASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"THR A 332;GLY A 206;GLU A  73;SER A 336;ILE A 204","None","1.46A","1odiB-6fn1A:undetectable","1odiB-6fn1A:16.88"],["1ODI_C_ADNC1238_1","PURINE NUCLEOSIDE PHOSPHORYLASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"THR A 332;GLY A 206;GLU A  73;SER A 336;ILE A 204","None","1.41A","1odiC-6fn1A:undetectable","1odiC-6fn1A:16.88"],["1ODI_D_ADND1237_1","PURINE NUCLEOSIDE PHOSPHORYLASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"THR A 332;GLY A 206;GLU A  73;SER A 336;ILE A 204","None","1.46A","1odiD-6fn1A:undetectable","1odiD-6fn1A:16.88"],["1SDU_B_MK1B902_1","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ARG A1221;LEU A1198;ALA A1184;GLY A1177;GLY A1178","None","0.93A","1sduA-6fn1A:undetectable","1sduA-6fn1A:21.21"],["1SDV_B_MK1B902_1","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ARG A1221;LEU A1198;ALA A1184;GLY A1177;GLY A1178","None","0.93A","1sdvA-6fn1A:undetectable","1sdvA-6fn1A:21.21"],["1XOQ_A_ROFA502_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"LEU A 832;TYR A 997;THR A1001;SER A 695;PHE A 696","None","1.11A","1xoqA-6fn1A:undetectable","1xoqA-6fn1A:undetectable"],["1XOQ_B_ROFB501_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"LEU A 832;TYR A 997;THR A1001;SER A 695;PHE A 696","None","1.12A","1xoqB-6fn1A:undetectable","1xoqB-6fn1A:undetectable"],["1ZQ9_A_SAMA4000_1","PROBABLE DIMETHYLADENOSINE TRANSFERASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",3,"GLY A 609;GLU A 607;ASN A 610","None","0.71A","1zq9A-6fn1A:undetectable","1zq9A-6fn1A:undetectable"],["2EIN_W_CHDW1060_0","CYTOCHROME C OXIDASE POLYPEPTIDE VIIA-HEART;CYTOCHROME C OXIDASE SUBUNIT 1","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"ILE A 895;TYR A 489;ARG A 488;THR A 482","None","1.03A","2einN-6fn1A:0.3;2einW-6fn1A:undetectable","2einN-6fn1A:undetectable;2einW-6fn1A:undetectable"],["2QHF_A_NCAA493_0","CHORISMATE SYNTHASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"MET A  38;ILE A 185;ALA A 357;ALA A 361;VAL A 364","None","0.94A","2qhfA-6fn1A:undetectable","2qhfA-6fn1A:undetectable"],["2VAV_F_CSCF1383_2","ACETYL-COA--DEACETYLCEPHALOSPORIN C ACETYLTRANSFERASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",3,"LEU A 137;MET A 931;MET A 877","None","0.95A","2vavF-6fn1A:undetectable","2vavF-6fn1A:10.86"],["2WX2_B_TPFB1460_1","LANOSTEROL 14-ALPHA-DEMETHYLASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"TYR A 789;ALA A 249;ALA A 253;LEU A 796","None","1.03A","2wx2B-6fn1A:undetectable","2wx2B-6fn1A:10.99"],["2Y6R_B_CTCB1385_0","TETX2 PROTEIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"MET A 196;PHE A 199;GLY A 202;GLY A 225","None","0.95A","2y6rB-6fn1A:undetectable","2y6rB-6fn1A:undetectable"],["2YZQ_A_SAMA6075_0","PUTATIVE UNCHARACTERIZED PROTEIN PH1780","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ILE A 460;ILE A 387;ILE A 468;GLU A 467;PRO A 384","None","1.24A","2yzqA-6fn1A:undetectable","2yzqA-6fn1A:undetectable"],["2ZIA_A_CL9A401_2","DEOXYCYTIDINE KINASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"VAL A 462;ASP A 456;LEU A 391;ARG A 466","None","1.26A","2ziaA-6fn1A:1.3","2ziaA-6fn1A:11.49"],["3BOG_D_DHID8_0","6.5 KDA GLYCINE-RICH ANTIFREEZE PROTEIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"SER A1070;GLY A1069;GLY A1072;GLY A1248","None","0.80A","3bogB-6fn1A:undetectable;3bogD-6fn1A:undetectable","3bogB-6fn1A:undetectable;3bogD-6fn1A:undetectable"],["3BUR_A_TESA339_1","3-OXO-5-BETA-STEROID 4-DEHYDROGENASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ILE A 460;THR A 580;SER A 418;ASN A 390;VAL A 416","None","1.43A","3burA-6fn1A:undetectable","3burA-6fn1A:14.69"],["3ELZ_B_CHDB151_0","ILEAL BILE ACID-BINDING PROTEIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ILE A 582;ILE A 584;GLY A 426;VAL A 591;LEU A 414","None","1.41A","3elzB-6fn1A:undetectable","3elzB-6fn1A:undetectable"],["3KP2_A_PNNA5001_0","TRANSCRIPTIONAL REGULATOR TCAR","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"ASN A 902;THR A 905;LEU A 909;ARG A 542","None","0.92A","3kp2A-6fn1A:1.2;3kp2B-6fn1A:undetectable","3kp2A-6fn1A:undetectable;3kp2B-6fn1A:undetectable"],["3KP6_A_SALA3005_1","TRANSCRIPTIONAL REGULATOR TCAR","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"ASN A 902;THR A 905;LEU A 909;ARG A 542","None","0.98A","3kp6A-6fn1A:undetectable","3kp6A-6fn1A:21.13"],["3N3I_A_ROCA201_2","PROTEASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"PRO A  65;ILE A  59;GLY A  61;VAL A 132","None","0.87A","3n3iA-6fn1A:undetectable","3n3iA-6fn1A:16.67"],["3NLY_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"PHE A  78;GLU A 971;SER A 969;VAL A 963","None","1.34A","3nlyA-6fn1A:undetectable;3nlyB-6fn1A:undetectable","3nlyA-6fn1A:14.60;3nlyB-6fn1A:14.60"],["3NMU_J_SAMJ228_0","FIBRILLARIN-LIKE RRNA\/TRNA 2'-O-METHYLTRANSFERASE;NOP5\/NOP56 RELATED PROTEIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ALA A 868;ILE A 980;PHE A 982;ALA A 979;GLN A 724","None;None;ZQU A1305 ( 4.6A);None;ZQU A1304 (-4.2A)","1.24A","3nmuB-6fn1A:3.4;3nmuJ-6fn1A:undetectable","3nmuB-6fn1A:undetectable;3nmuJ-6fn1A:undetectable"],["3OF4_B_ACTB313_0","NITROREDUCTASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",3,"ALA A 571;VAL A 568;GLN A 536","None","0.68A","3of4B-6fn1A:undetectable","3of4B-6fn1A:undetectable"],["3OGP_A_017A200_2","FIV PROTEASE;FIV PROTEASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"LEU A 858;VAL A 864;GLY A 843;ILE A 847;LEU A 861","None","1.33A","3ogpB-6fn1A:undetectable","3ogpB-6fn1A:23.97"],["3PGH_A_FLPA701_1","CYCLOOXYGENASE-2","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"VAL A1059;VAL A1078;LEU A1081;VAL A1093;LEU A1057","None","0.93A","3pghA-6fn1A:undetectable","3pghA-6fn1A:7.35"],["3PRS_A_RITA1001_2","ENDOTHIAPEPSIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"GLY A 603;GLY A 429;THR A 434;TYR A 400;ILE A 408","None","1.15A","3prsA-6fn1A:undetectable","3prsA-6fn1A:11.18"],["3RQL_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"PHE A  78;GLU A 971;SER A 969;VAL A 963","None","1.33A","3rqlA-6fn1A:2.8;3rqlB-6fn1A:undetectable","3rqlA-6fn1A:14.60;3rqlB-6fn1A:14.60"],["3UQ6_B_ADNB401_2","ADENOSINE KINASE, PUTATIVE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"LEU A 883;GLY A 880;MET A 191;PHE A 941","None","1.03A","3uq6B-6fn1A:undetectable","3uq6B-6fn1A:12.57"],["3UWL_D_FOZD316_0","THYMIDYLATE SYNTHASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"LEU A 424;LEU A 409;GLY A 603;PHE A 600;ILE A 396","None","1.03A","3uwlD-6fn1A:undetectable","3uwlD-6fn1A:undetectable"],["3VAQ_B_ADNB401_2","PUTATIVE ADENOSINE KINASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"LEU A 883;GLY A 880;MET A 191;PHE A 941","None","1.06A","3vaqB-6fn1A:undetectable","3vaqB-6fn1A:12.57"],["3WG7_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"ILE A 895;TYR A 489;ARG A 488;THR A 482","None","1.02A","3wg7N-6fn1A:3.1;3wg7W-6fn1A:undetectable","3wg7N-6fn1A:undetectable;3wg7W-6fn1A:undetectable"],["4A6D_A_SAMA1350_0","HYDROXYINDOLE O-METHYLTRANSFERASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"PHE A 696;GLY A 829;GLY A 826;ILE A 699;ALA A 833","None","1.04A","4a6dA-6fn1A:undetectable","4a6dA-6fn1A:undetectable"],["4A6E_A_SAMA1349_0","HYDROXYINDOLE O-METHYLTRANSFERASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"PHE A 696;GLY A 829;GLY A 826;ILE A 699;ALA A 833","None","1.12A","4a6eA-6fn1A:undetectable","4a6eA-6fn1A:undetectable"],["4CAP_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"PHE A  78;GLU A 971;SER A 969;VAL A 963","None","1.34A","4capA-6fn1A:undetectable;4capB-6fn1A:undetectable","4capA-6fn1A:14.60;4capB-6fn1A:14.60"],["4EB6_C_VLBC503_1","TUBULIN BETA CHAIN;TUBULIN ALPHA CHAIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"VAL A1034;THR A1064;ILE A1114;VAL A1079;ILE A1229","None","1.41A","4eb6B-6fn1A:undetectable;4eb6C-6fn1A:undetectable","4eb6B-6fn1A:11.49;4eb6C-6fn1A:12.44"],["4KOE_F_TR6F101_1","DNA TOPOISOMERASE 4 SUBUNIT A;DNA TOPOISOMERASE 4 SUBUNIT A;DNA TOPOISOMERASE 4 SUBUNIT B;E-SITE DNA2","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"SER A1234;ARG A1232;GLY A1178;ASP A1206","None","0.95A","4koeA-6fn1A:undetectable;4koeB-6fn1A:undetectable;4koeC-6fn1A:undetectable","4koeA-6fn1A:10.55;4koeB-6fn1A:10.55;4koeC-6fn1A:16.24"],["4KOE_H_TR6H101_1","DNA TOPOISOMERASE 4 SUBUNIT A;DNA TOPOISOMERASE 4 SUBUNIT A;DNA TOPOISOMERASE 4 SUBUNIT B;E-SITE DNA4","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"ARG A1232;SER A1234;GLY A1178;ASP A1206","None","0.91A","4koeA-6fn1A:undetectable;4koeB-6fn1A:undetectable;4koeD-6fn1A:undetectable","4koeA-6fn1A:10.55;4koeB-6fn1A:10.55;4koeD-6fn1A:16.24"],["4KT0_A_PQNA2001_1","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1;PHOTOSYSTEM I REACTION CENTER SUBUNIT IX","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"SER A 830;GLY A 829;LEU A 783;GLY A 780;LEU A 257","None","1.14A","4kt0A-6fn1A:3.4;4kt0J-6fn1A:1.5","4kt0A-6fn1A:8.85;4kt0J-6fn1A:23.29"],["4LA0_B_198B601_1","SERUM ALBUMIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"LEU A1259;ALA A1073;LYS A1251;GLU A1252;LEU A1065","None","1.12A","4la0B-6fn1A:undetectable","4la0B-6fn1A:7.85"],["4O1E_A_C2FA3000_0","DIHYDROPTEROATE SYNTHASE DHPS","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ILE A 839;ILE A 867;GLY A 988;SER A 991;ASN A 720","None","1.10A","4o1eA-6fn1A:undetectable","4o1eA-6fn1A:undetectable"],["4O1E_B_C2FB4000_0","DIHYDROPTEROATE SYNTHASE DHPS","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ILE A 839;ILE A 867;GLY A 988;SER A 991;ASN A 720","None","1.08A","4o1eB-6fn1A:undetectable","4o1eB-6fn1A:undetectable"],["4O8F_B_BRLB501_2","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"ILE A 718;GLY A 721;ILE A 848;ILE A 839","None","0.63A","4o8fB-6fn1A:undetectable","4o8fB-6fn1A:16.22"],["4OLT_B_GCSB302_1","CHITOSANASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"ARG A1046;THR A1045;ASP A 804;TYR A1086","None","1.46A","4oltB-6fn1A:undetectable","4oltB-6fn1A:16.39"],["4QVW_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",6,"THR A 175;ALA A 896;THR A 897;ALA A 899;GLY A 891;SER A 892","None","1.38A","4qvwK-6fn1A:undetectable;4qvwL-6fn1A:undetectable","4qvwK-6fn1A:17.70;4qvwL-6fn1A:15.18"],["4QVW_K_BO2K301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",6,"THR A 175;ALA A 896;THR A 897;GLY A 891;SER A 892;SER A 922","None","1.48A","4qvwK-6fn1A:undetectable;4qvwL-6fn1A:undetectable","4qvwK-6fn1A:17.70;4qvwL-6fn1A:15.18"],["4QVW_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",6,"THR A 175;ALA A 896;THR A 897;ALA A 899;GLY A 891;SER A 892","None","1.39A","4qvwY-6fn1A:undetectable;4qvwZ-6fn1A:undetectable","4qvwY-6fn1A:17.70;4qvwZ-6fn1A:15.18"],["4QVW_Y_BO2Y301_1","PROTEASOME SUBUNIT BETA TYPE-5;PROTEASOME SUBUNIT BETA TYPE-6","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",6,"THR A 175;ALA A 896;THR A 897;GLY A 891;SER A 892;SER A 922","None","1.48A","4qvwY-6fn1A:undetectable;4qvwZ-6fn1A:undetectable","4qvwY-6fn1A:17.70;4qvwZ-6fn1A:15.18"],["4V3Y_B_H4BB760_1","NITRIC OXIDE SYNTHASE, BRAIN;NITRIC OXIDE SYNTHASE, BRAIN","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"PHE A  78;GLU A 971;SER A 969;VAL A 963","None","1.35A","4v3yA-6fn1A:undetectable;4v3yB-6fn1A:undetectable","4v3yA-6fn1A:14.60;4v3yB-6fn1A:14.60"],["5B1B_W_CHDW101_0","CYTOCHROME C OXIDASE SUBUNIT 1;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ILE A 895;PHE A 915;TYR A 489;ARG A 488;THR A 482","None","1.42A","5b1bN-6fn1A:2.9;5b1bW-6fn1A:undetectable","5b1bN-6fn1A:undetectable;5b1bW-6fn1A:undetectable"],["5DXE_A_ESTA1000_1","ESTROGEN RECEPTOR","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"GLU A 607;LEU A 614;MET A 615;LEU A 588","None","0.96A","5dxeA-6fn1A:3.1","5dxeA-6fn1A:17.53"],["5E26_A_PAUA602_0","PANTOTHENATE KINASE 2, MITOCHONDRIAL","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"GLY A 299;SER A 765;GLY A 762;ALA A 301","None","0.82A","5e26A-6fn1A:undetectable;5e26B-6fn1A:undetectable","5e26A-6fn1A:undetectable;5e26B-6fn1A:undetectable"],["5E26_D_PAUD601_0","PANTOTHENATE KINASE 2, MITOCHONDRIAL","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"ALA A 301;GLY A 299;SER A 765;GLY A 762","None","0.84A","5e26C-6fn1A:undetectable;5e26D-6fn1A:undetectable","5e26C-6fn1A:undetectable;5e26D-6fn1A:undetectable"],["5FSA_A_X2NA590_1","CYP51 VARIANT1","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"PHE A 313;ILE A 734;PHE A 335;PHE A 982;PHE A 977","None;None;ZQU A1304 ( 3.8A);ZQU A1305 ( 4.6A);None","1.08A","5fsaA-6fn1A:undetectable","5fsaA-6fn1A:10.52"],["5IKT_B_TLFB601_0","PROSTAGLANDIN G\/H SYNTHASE 2","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"VAL A1059;VAL A1078;LEU A1081;VAL A1093;LEU A1057","None","1.00A","5iktB-6fn1A:undetectable","5iktB-6fn1A:undetectable"],["5IWU_A_ERYA404_1","MACROLIDE 2'-PHOSPHOTRANSFERASE II","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"GLY A1072;ASP A1199;ILE A1227;TYR A1043","None","1.13A","5iwuA-6fn1A:undetectable","5iwuA-6fn1A:undetectable"],["5KR0_A_478A101_1","PROTEASE E35D-APV","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ALA A1239;ASP A1240;ILE A1229;VAL A1244;ILE A1242","None","1.16A","5kr0A-6fn1A:undetectable","5kr0A-6fn1A:21.21"],["5MVM_A_PFLA510_1","PROTON-GATED ION CHANNEL;PROTON-GATED ION CHANNEL","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"ILE A 217;ALA A 219;ILE A 220;ALA A 312;LEU A 311","None","1.12A","5mvmA-6fn1A:3.6;5mvmE-6fn1A:1.6","5mvmA-6fn1A:17.50;5mvmE-6fn1A:17.50"],["5UC1_A_486A801_1","GLUCOCORTICOID RECEPTOR","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"LEU A 412;LEU A 409;GLY A 603;GLY A 602;LEU A 424","None","0.97A","5uc1A-6fn1A:undetectable","5uc1A-6fn1A:21.25"],["5UC1_B_486B801_2","GLUCOCORTICOID RECEPTOR","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"LEU A 412;LEU A 409;GLY A 603;GLY A 602;LEU A 424","None","0.96A","5uc1B-6fn1A:undetectable","5uc1B-6fn1A:21.25"],["5V5Z_A_1YNA602_1","LANOSTEROL 14-ALPHA DEMETHYLASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"PHE A 313;ILE A 734;PHE A 335;PHE A 982;PHE A 977","None;None;ZQU A1304 ( 3.8A);ZQU A1305 ( 4.6A);None","1.20A","5v5zA-6fn1A:undetectable","5v5zA-6fn1A:9.49"],["5YW0_A_ACTA411_0","UNCHARACTERIZED PROTEIN KDOO","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",3,"LYS A 289;LEU A 286;ARG A 285","None","0.95A","5yw0A-6fn1A:undetectable","5yw0A-6fn1A:undetectable"],["5ZRF_D_EVPD101_1",";","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"GLY A 190;ASP A 187;GLN A 945;MET A 948","None;None;ZQU A1305 (-3.8A);ZQU A1305 (-3.4A)","1.30A","5zrfB-6fn1A:undetectable","5zrfB-6fn1A:8.86"],["6B89_A_NOVA403_2","LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB;LIPOPOLYSACCHARIDE EXPORT SYSTEM ATP-BINDING PROTEIN LPTB","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"ARG A 542;ARG A 546;LEU A 544;ALA A 571","None","0.91A","6b89B-6fn1A:21.5","6b89B-6fn1A:18.99"],["6CBZ_A_ESTA601_1","ESTROGEN RECEPTOR","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",4,"GLU A 607;LEU A 614;MET A 615;LEU A 588","None","1.00A","6cbzA-6fn1A:undetectable","6cbzA-6fn1A:24.47"],["6HQB_A_PQNA2001_0","PHOTOSYSTEM I P700 CHLOROPHYLL A APOPROTEIN A1;PHOTOSYSTEM I REACTION CENTER SUBUNIT IX","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"SER A 830;GLY A 829;LEU A 783;GLY A 780;LEU A 257","None","1.21A","6hqbA-6fn1A:4.4;6hqbJ-6fn1A:1.4","6hqbA-6fn1A:19.05;6hqbJ-6fn1A:23.29"],["6QXS_B_FOZB403_0","THYMIDYLATE SYNTHASE","6fn1","HUMAN-MOUSE CHIMERIC ABCB1 (ABCBHM)","Homo sapiens",5,"LEU A 424;LEU A 409;GLY A 603;PHE A 600;ILE A 396","None","1.08A","6qxsB-6fn1A:undetectable","6qxsB-6fn1A:undetectable"]]